There's a specific conversation that happens about 6 months after a comprehensive ophthalmology practice sells. The retiring physician has handed off most clinical responsibility, the successor physician is running most of the surgical load, the new MD is competent, patients are happy, and yet the referrals from the optometrists who built the practice over 20 years have started slowing down. Nobody saw it coming because nothing obvious changed. The phones still ring. The schedule still fills. The OD network just sends fewer surgical cases each month, quietly, and by month 9 the cumulative decline is material.

Nobody warned the practice owner that this was coming, because the people who typically advise ophthalmology practice sales, brokers, attorneys, accountants, and investment banks, rarely live inside the operational reality of what an OD referral pipeline actually requires to maintain. The legal transfer of the practice happens at closing, the patient records migrate, and the signage changes. What doesn't transfer automatically is the 15-year relationship between the retiring MD and the 40 optometrists who have been sending their surgical cases there because they trusted the surgeon.

The OD referral pipeline is one of the most valuable assets inside a comprehensive ophthalmology practice. It's also one of the most fragile, and in most practice sales, it's the asset that takes the largest silent haircut in the first year post-close.

Why the Ophthalmology OD Referral Relationship Is Structurally Different from Other Patient Sources

Brin and Griffin's 1995 meta-analysis covering 15 separate studies found that optometrists refer 3.83% of their patients to ophthalmologists and 5.50% to all other providers. McKee's 2009 Belfast cohort analysis found that optometrists were the single largest referral source to an ophthalmology practice, sending 323 of approximately 566 referrals tracked, with general practitioners sending 243. Cataract was the most common reason for OD-to-MD referral in both studies, followed by glaucoma and retinal conditions.

An OIG Advisory Opinion 22-14 issued in June 2022 disclosed that the requesting ophthalmology practice received approximately 50% of its surgical referrals from local optometrists, with approximately 30% of those patients returning to the referring OD for comanaged post-operative care. That disclosure is useful because it's one of the few publicly documented data points on how heavily comprehensive ophthalmology practices depend on OD referrals at the surgical level.

The economics published by John Pinto in Healio put the passive income per employed OD in an ophthalmology practice at approximately $50,000 annually, meaning an MD who employs or formally affiliates with 10 optometrists generates $500,000 in passive income from the OD-driven surgical pipeline. A Review of Ophthalmology case study featuring a practice with more than 100 optometrists in its referral network documented greater than $1 million in yearly optometric referral revenue, accounting for approximately 8% of total clinic income. A practice that loses a third of its OD network in the year after a sale is losing roughly a third of that revenue, and nobody itemized the exposure before closing.

What makes these relationships structurally fragile is that they aren't contractual, aren't written down, and aren't protected by Stark or anti-kickback statute safe harbors unless the practice has built formal comanagement arrangements under OIG Advisory Opinion 11-14 from October 2011, which provides the federal framework for permissible OD-MD cataract comanagement including premium IOL patients. Most referral relationships run on trust, clinical reputation, and post-operative communication quality, and trust doesn't transfer at closing.

The Ophthalmology Practice Sale Communication Sequence That Actually Preserves OD Referrals

The operational playbook experienced brokers use to protect OD referral pipelines during a practice transition has roughly six components, and almost none of it gets written into the purchase agreement. The work starts 60 days before close, when the retiring physician writes a personal letter to every referring OD in the network introducing the successor surgeon by name and explaining the transition. The letter is signed personally rather than printed on letterhead, and the distribution list is limited to actively referring ODs rather than the full marketing database. Around the same time, the successor physician records a short video interview with the retiring physician covering clinical philosophy, fellowship training, and the handoff plan, and that video gets distributed to the same OD list before close. Production value matters less than the fact that the retiring physician is on camera personally endorsing the successor.

The most important component is also the one most successor physicians resist. During the first 60 days post-close, the successor physician spends time meeting referring optometrists in person, one by one, at the OD's office rather than inside the practice or over Zoom. The site of the meeting carries meaning in optometry culture, and showing up at the OD's office communicates respect for the relationship in a way that a video call cannot replicate. This is the single most important step for pipeline preservation, and it's also the step that gets skipped the most often because it feels time-consuming during a period when the successor is already managing a full clinical handoff. The ODs who never get that visit quietly start sending cases elsewhere, and by the time the successor notices, the relationship is already gone.

The remaining three components are about operational consistency. The post-operative communication protocol stays exactly the same as what the retiring physician ran, down to the 48-hour post-op note turnaround and the personal phone call to the OD on any complicated case. The retiring physician stays clinically active in a limited role for at least 6 months, visibly in the practice and available for consultation on complex cases, which insures against the perception that the clinical character has changed with the ownership. And for at least 9 months post-close, the successor physician makes no operational changes that are visible to the referring OD network, which means no new comanagement protocols, no pricing changes on comanaged cataract fees, and no renegotiation of post-op timelines. Stability signals continuity, and continuity preserves referrals.

Why Ophthalmology PE Acquisitions Produce Different Referral Pipeline Outcomes

EyeCare Partners was originally announced in 2019 with 500 optometrists and 85 ophthalmologists before subsequent mergers, including the CEI Vision Partners absorption at the end of 2021. The platform's explicit strategy, as documented in Provident Healthcare Partners' published analysis, was to vertically integrate optometrists into the MSO structure in order to capture OD referral flow inside the platform rather than relying on external referral relationships. That structural choice produces a different referral pipeline outcome than a permanent-hold succession, and the difference is not subtle.

In a PE platform, the referring OD network typically gets absorbed into the MSO over time, either through direct employment, practice acquisition, or formal affiliation agreements. External ODs who don't join the platform see their referral volume decline as the platform routes surgical cases through internally affiliated ODs, and the retiring physician who sold their practice to the platform watches the network they spent 20 years building get reallocated to new contractual relationships they have no say over. For a retiring ophthalmologist whose external OD referral network is the backbone of the practice, a PE acquisition can accelerate the haircut rather than prevent it.

The successor physician working inside a platform has a different incentive structure than a successor physician working inside a permanent-hold practice. The platform's incentive is to capture maximum referral flow internally, which often means converting independent ODs into employed or affiliated relationships that reduce their autonomy. The independent practice's incentive is to preserve every external OD relationship regardless of whether the OD ever joins a formal structure. Those two incentive sets produce different outcomes for the same network of optometrists, and the retiring physician usually doesn't know which outcome they've signed up for until 18 months after closing.

What the Ophthalmology Stark and Anti-Kickback Rules Require During Referral Transitions

Stark Law operates as a strict liability statute, which means the law applies regardless of intent. Under Stark, a buyer cannot condition the sale price of an ophthalmology practice on maintaining existing patient referrals. The anti-kickback statute adds criminal penalties for arrangements designed to induce referrals, which means both the buyer and the seller have legal exposure if the purchase agreement ties any portion of the price to the continuation of specific referral flows.

What the framework allows, under OIG Advisory Opinion 11-14 and OIG Advisory Opinion 22-14, is formal comanagement under specific structural conditions: written informed consent from the patient, a written transfer agreement between the MD and OD, services performed within the OD's scope of practice, and fair market value compensation for the comanaged portion of care. The ASCRS and AAO Joint Position Paper on Postoperative Care, reaffirmed most recently in 2016, treats comanagement as an exception to direct surgeon follow-up rather than the default.

For a practice owner thinking about sale, the framework matters because the formal comanagement arrangements transfer cleanly through a change of ownership. The informal referral relationships don't. A practice that has built its OD pipeline entirely through informal relationships has less to transfer at sale than a practice that has converted the strongest relationships into formal comanagement agreements during the 2 to 3 years before exit. That's a structural choice that has to be made during the operating years, not during the sale process.

The 6-month post-close conversation the retiring physician didn't see coming happens because the pipeline didn't transfer, and the pipeline didn't transfer because it was never structured to transfer. By the time the practice is on the market, it either carries contractual depth or it doesn't, and the retiring physician's next 20 years of legacy depend on which of those conditions is true.

This article is for general educational purposes and is not legal or financial advice.

Verdira is a healthcare acquisition platform focused on ophthalmology practices. Physician ownership. Transparent structure. No volume quotas. If you're a practice owner thinking about succession or a physician exploring ownership, we're open to thoughtful conversations.

Contact info@verdira.com | 307-381-3734 | verdira.com